Heat shock proteins and immunity: application of hyperthermia for immunomodulation
/in Hyperthermia, International Publications /von 2009-12-01 / Int J Hyperthermia 2009 Dec;25(8):610-6Heat-shock protein vaccines as active immunotherapy against human gliomas
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications /von 2009-11-01 / Expert Rev Anticancer Ther 2009 Nov;9(11):1577-82Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia
/in Hyperthermia, International Publications /von 2009-11-01 / Radiother Oncol 2009 Nov;93(2):358-63Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine
/in Dendritic Cells, Hyperthermia, International Publications /von 2009-09-22 / Mol. Ther. 2009 Dec;17(12):2049-57Enhanced T-cell activation by immature dendritic cells loaded with HSP70-expressing heat-killed melanoma cells
/in Dendritic Cells, Hyperthermia, International Publications /von 2009-09-15 / Exp. Dermatol. 2010 Feb;19(2):108-16Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells
/in Dendritic Cells, Hyperthermia, International Publications /von 2009-09-01 / Prostate 2009 Sep;69(12):1343-52Hyperthermia as an immunotherapy strategy for cancer
/in Hyperthermia, International Publications /von 2009-06-01 / Curr Opin Investig Drugs 2009 Jun;10(6):550-8Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2009-05-01 / Int J Hyperthermia 2009 May;25(3):210-9Nitric oxide-mediated inhibition of NFkappaB regulates hyperthermia-induced apoptosis
/in Hyperthermia, International Publications /von 2009-04-15 / J. Cell. Biochem. 2009 Apr;106(6):999-1009
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de